Home

Michael H. Mulroy

CIK 1509725 · President and CEO · last filed 2026-07-02

Michael H. Mulroy is a President and CEO who has filed 47 SEC Form 4 insider transactions across 7 companies since 2011. The most recent filing, for LCTX, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $319.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$319.7K

Companies

7

Total Filings

47

Lifetime Open-Market Net

-$2.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LCTX Director 298,555 $1.07 $319.5K $32.4K 10 2026-07-02
Serina Therapeutics, Inc. (AGE) Delisted Director — $11.10 — $0 1 2019-03-13
Asterias Biotherapeutics, Inc. (AST) Delisted President and CEO 350,210 — — $54.9K 13 2019-03-05
Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Director 32,550 — — $0 4 2018-07-03
Asterias Biotherapeutics, Inc. (AST.WS) Delisted President and CEO 1,537 — — $5.0K 2 2017-09-27
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted See Remarks 65,714 — — -$2.44M 11 2014-08-13
BTX Director 35 $7.87 $275 $0 3 2013-10-10

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 LCTX Grant (A) — $0 EDGAR
2025-07-02 LCTX Grant (A) — $0 EDGAR
2024-11-25 LCTX Buy (P) +40,000 $22.6K EDGAR
2024-07-03 LCTX Grant (A) — $0 EDGAR
2023-07-03 LCTX Grant (A) — $0 EDGAR
2022-07-06 LCTX Grant (A) — $0 EDGAR
2022-03-25 LCTX Buy (P) +7,000 $9.8K EDGAR
2021-07-01 LCTX Grant (A) — $0 EDGAR
2021-06-21 LCTX Exer (M) +24,720 $54.4K EDGAR
2020-07-02 LCTX Grant (A) — $0 EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.